CRNX position history
The shares of Crinetics Pharmaceuticals In (CRNX) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q3: 361,904 shares, $11M, 0.05% of portfolio, New
- 2023 Q4: 122,904 shares, $4.4M, 0.02% of portfolio, Reduce −66.0%
- 2024 Q1: 10,000 shares, $468K, <0.01% of portfolio, Reduce −91.9%
- 2024 Q2: 497,000 shares, $22M, 0.11% of portfolio, Add +4870.0%
- 2024 Q3: 1,162,000 shares, $59M, 0.29% of portfolio, Add +133.8%
- 2024 Q4: 4,075,098 shares, $208M, 1.1% of portfolio, Add +250.7%
- 2025 Q1: 4,605,098 shares, $154M, 0.86% of portfolio, Add +13.0%
- 2025 Q2: 4,646,098 shares, $134M, 0.58% of portfolio, Add +0.9%
- 2025 Q3: 11,540,196 shares, $481M, 2.0% of portfolio, Add +148.4%
- 2025 Q4: 6,933,098 shares, $323M, 1.5% of portfolio, Reduce −39.9%
- 2026 Q1: 8,338,098 shares, $303M, 1.7% of portfolio, Add +20.3%
- 2026 Q2: 8,989,098 shares, $336M, 1.6% of portfolio, Add +7.8%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|